Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06423261
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-04-30
Brief Title:
Safety Tolerability Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects
Sponsor:
Zhejiang Echon Biopharm Limited
Organization:
Zhejiang Echon Biopharm Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07-29
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-30
First Submit QC Date:
May 15 2024
Study First Post Date:
2024-05-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-31
Last Update Post Date:
2024-06-03
Last Update Post Date Type:
ACTUAL